title: Survival and recurrence in nonmycosis fungoides primary cutaneous lymphoma.
abstract: OBJECTIVE
  To evaluate overall and relapse-free survival (RFS) in patients with nonmycosis fungoides (non-MF) primary cutaneous lymphoma (PCL).
  
  
  METHODS
  Thirty-eight patients with PCL excluding cases of MF treated between 1993 and 2006 were analyzed retrospectively. Survival statistics were estimated by the methods of Kaplan and Meier, and univariate and multivariate significance testing were performed by Cox regression analysis.
  
  
  RESULTS
  The median follow-up was 34.6 months (range, 2-138.3 months). The overall survival for the entire study population, at 5 and 10 years, was 97% and 78%, respectively. The RFS for the entire study population, at 5 and 10 years, was 30% and 22%, respectively. For those who received radiotherapy (RT) as a component of their initial therapy, the RFS at 5 and 10 years was 48% and 36%, respectively. Among those receiving RT who relapsed, the site of relapse was out-of-field in 82% of the cases. In our multivariate analysis, only RT as a component of the initial therapy and the absence of bulky disease had a statistically significant improvement in RFS (P = 0.01 and <0.01, respectively).
  
  
  CONCLUSIONS
  RT improves the local control and RFS of patients with non-MF PCL.
authors.affiliation: University of Utah and Huntsman Cancer Institute, Salt Lake City, UT, USA. jonathan.tward@hci.utah.edu
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Tward
authors.forename: Charles V
authors.initials: CV
authors.lastname: Cachoeira
authors.forename: Mohammed E
authors.initials: ME
authors.lastname: Salama
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Lee
authors.forename: Glen
authors.initials: G
authors.lastname: Bowen
authors.forename: Sherrie L
authors.initials: SL
authors.lastname: Perkins
authors.forename: Martha
authors.initials: M
authors.lastname: Glenn
authors.forename: Michael
authors.initials: M
authors.lastname: Confer
authors.forename: David K
authors.initials: DK
authors.lastname: Gaffney
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017024:Chemotherapy, Adjuvant; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D053208:Kaplan-Meier Estimate; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009364:Neoplasm Recurrence, Local / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D011701:PUVA Therapy; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D055815:Young Adult